Rami Levy - Intercure Chief Canndoc

INCR Stock  ILS 484.80  8.20  1.66%   

Insider

Rami Levy is Chief Canndoc of Intercure
Age 58
Phone(972) 77 460 5012
Webwww.intercure.co

Intercure Management Efficiency

The company has return on total asset (ROA) of 0.0538 % which means that it generated a profit of $0.0538 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0736 %, meaning that it generated $0.0736 on every $100 dollars invested by stockholders. Intercure's management efficiency ratios could be used to measure how well Intercure manages its routine affairs as well as how well it operates its assets and liabilities.
Intercure has accumulated 11.95 M in total debt with debt to equity ratio (D/E) of 64.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intercure has a current ratio of 0.3, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Intercure until it has trouble settling it off, either with new capital or with free cash flow. So, Intercure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intercure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intercure to invest in growth at high rates of return. When we think about Intercure's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Arnon MDClal Biotechnology Industries
54
Tomer RavedB Communications
38
Omer ShoorPhotomyne
45
Shiran ManorClal Biotechnology Industries
N/A
Nir LahaZanlakol
53
Advocate GevaHarelICL Israel Chemicals
46
Yochay LifshitzZanlakol
59
Eli AmonICL Israel Chemicals
54
Amit KurlandBezeq Israeli Telecommunication
52
Meni BaruchBezeq Israeli Telecommunication
48
Liron KutziPhotomyne
N/A
Amir MeshulamICL Israel Chemicals
43
Ariella RabanKamada
47
Pr MDClal Biotechnology Industries
77
Maya GrinfeldICL Israel Chemicals
N/A
Ruth SassoverZanlakol
78
Anantha DesikanICL Israel Chemicals
51
Ilan ChaikinB Communications
69
Tobi FischbeinBezeq Israeli Telecommunication
50
Eran NirKamada
50
Iris SadehClal Biotechnology Industries
N/A
InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and internationally. InterCure Ltd. was founded in 1994 and is based in Hadera, Israel. INTERCURE LTD is traded on Tel Aviv Stock Exchange in Israel. Intercure (INCR) is traded on Tel Aviv Stock Exchange in Israel and employs 350 people.

Management Performance

Intercure Leadership Team

Elected by the shareholders, the Intercure's board of directors comprises two types of representatives: Intercure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intercure. The board's role is to monitor Intercure's management team and ensure that shareholders' interests are well served. Intercure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intercure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amos Cohen, Chief Officer
Alexander Rabinovitch, CEO, Director
Advocate Ohayon, CoFounder Ltd
OriMoni Mimon, CoFounder Ltd
Omri Batzir, Co Controller
Rami Levy, Chief Canndoc

Intercure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intercure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Intercure Stock

Intercure financial ratios help investors to determine whether Intercure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intercure with respect to the benefits of owning Intercure security.